Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer

Mediators of Inflammation

Volumn 13, Issue 1, 2004, Pages 53-54

  Denizot, Yves ^a   Truffinet, Véronique ^a   Bouvier, Stéphane ^b   Gainant, Alain ^b   Cubertafond, Pierre ^b   Mathonnet, Muriel ^b  

^a CNRS   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Acetylhydrolase activity; Colorectal cancer; Phospholipase A2; Platelet activating factor

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; PHOSPHOLIPASE A2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME SYNTHESIS; FEMALE; HUMAN; INFLAMMATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UPREGULATION;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PROSPECTIVE STUDIES;

EID: 2442477548     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350410001664824     Document Type: Article

References (5)

1. Denizot Y. Platelet-activating factor: biosynthesis, biodegradation, actions. In: von Bruchhausen F, Walter U, eds. Handbook of Experimental Pharmacology: Platelets and their Factors, Berlin: Springer, 1997: 483-506.
2. Montrucchio G, Sapino A, Bussolati B, et al. Potential role of platelet-activating factor in human breast cancer. Am J Pathol 1998; 153: 1589-1596.
3. Denizot Y, Gainant A, Guglielmi L, Bouvier S, Cubertafond P, Mathonnet M. Tissue concentrations of platelet-activating factor in colorectal carcinoma: Inverse relationships with Dukes' stage of patients. Oncogene 2003; 22: 7222-7224.
4. 2 in patients with cancers of digestive organs. Res Commun Chem Pathol Pharmacol 1991; 74: 241-244.
5. 2 in inflammatory diseases. Clin Chem 1993; 39: 2453-2459.